CODX Historical Cash Flow
| CODX Stock | USD 0.74 0.01 0.77% |
Analysis of Co Diagnostics cash flow over time is an excellent tool to project Co Diagnostics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Borrowings of 1.3 M or Other Cashflows From Financing Activities of 16.2 M as it is a great indicator of Co Diagnostics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Co Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Co Diagnostics is a good buy for the upcoming year.
CODX |
About CODX Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in CODX balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which CODX's non-liquid assets can be easily converted into cash.
Co Diagnostics Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Co Diagnostics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Co Diagnostics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Co Diagnostics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Co Diagnostics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Co Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.At this time, Co Diagnostics' Change To Inventory is fairly stable compared to the past year. Other Cashflows From Financing Activities is likely to rise to about 16.2 M in 2024, despite the fact that Sale Purchase Of Stock is likely to grow to (1.3 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 669.5K | 1.4M | 1.4M | 1.4M | Depreciation | 335.4K | 1.3M | 1.2M | 1.3M |
Co Diagnostics cash flow statement Correlations
Click cells to compare fundamentals
Co Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Co Diagnostics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 5.9M | 19.7M | 450.4K | (14.2M) | (1.4M) | (1.3M) | |
| Change To Inventory | (179.0K) | (7.9M) | 5.7M | (3.5M) | 413.1K | 433.8K | |
| Investments | (322K) | (5.8M) | 3.6M | (56.7M) | (47.5M) | (45.2M) | |
| Change In Cash | (57.1K) | 42.1M | 45.6M | (65.6M) | (8.1M) | (7.7M) | |
| Total Cashflows From Investing Activities | (435.2K) | (5.8M) | 4.1M | (58.2M) | (52.4M) | (49.7M) | |
| Other Cashflows From Financing Activities | 407.2K | 272.7K | 450.4K | 177.9K | 15.4M | 16.2M | |
| Depreciation | 65.9K | 138.6K | 335.4K | 1.3M | 1.2M | 1.3M | |
| Capital Expenditures | 113.2K | 774.4K | 669.5K | 1.4M | 1.4M | 1.4M | |
| Total Cash From Operating Activities | (5.5M) | 28.2M | 41.1M | 6.6M | (22.1M) | (21.0M) | |
| Change To Operating Activities | (292.5K) | (6.5K) | (2.0M) | (224.1K) | (201.7K) | (211.8K) | |
| Net Income | (6.2M) | 42.5M | 36.7M | (14.2M) | (35.3M) | (33.6M) | |
| Total Cash From Financing Activities | 5.9M | 19.7M | 450.4K | (14.0M) | (1.4M) | (1.3M) | |
| End Period Cash Flow | 893.1K | 43.0M | 88.6M | 23.0M | 14.9M | 19.4M | |
| Other Cashflows From Investing Activities | (322K) | (5.0M) | 491.7K | (1.6K) | (1.4K) | (1.5K) | |
| Change To Netincome | 1.3M | 2.4M | 7.0M | 21.0M | 24.2M | 25.4M | |
| Change To Liabilities | (226.7K) | 4.1M | (455.2K) | (4.7M) | (4.2M) | (4.0M) | |
| Stock Based Compensation | 1.1M | 2.7M | 5.5M | 7.5M | 8.3M | 8.8M | |
| Free Cash Flow | (5.6M) | 27.4M | 40.4M | 5.1M | (23.4M) | (22.3M) | |
| Change In Working Capital | (818.3K) | (16.8M) | (2.9M) | 6.4M | 5.6M | 5.9M | |
| Begin Period Cash Flow | 950.2K | 893.1K | 43.0M | 88.6M | 23.0M | 19.7M | |
| Other Non Cash Items | 91.4K | 176.6K | 544.5K | 10.4M | 460.3K | 437.3K | |
| Change To Account Receivables | (121.5K) | (13.0M) | (8.7M) | 15.0M | 2.5M | 2.7M | |
| Cash And Cash Equivalents Changes | (57.1K) | 42.1M | 45.6M | (65.6M) | (59.1M) | (56.1M) | |
| Cash Flows Other Operating | (292.5K) | (6.5K) | (2.2M) | (8.2M) | (7.4M) | (7.0M) | |
| Change Receivables | (121.5K) | (13.0M) | (8.7M) | 15.0M | 17.2M | 18.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.